+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell & Gene Therapy Market - Global Forecast 2026-2032- Product Image
Cell & Gene Therapy Market - Global Forecast 2026-2032- Product Image
New

Cell & Gene Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011240
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell and gene therapy market is experiencing accelerated evolution, reshaping the landscape for both scientific innovation and commercial strategy. Senior leaders are navigating a pivotal juncture as new therapies move from research to clinical and industrial deployment, requiring agile decision-making.

Market Snapshot

According to the latest analysis, the cell and gene therapy market expanded from USD 19.47 billion in 2025 to USD 22.98 billion in 2026, reflecting sustained momentum. The market is projected to maintain a compound annual growth rate (CAGR) of 20.39%, reaching USD 71.38 billion by 2032. This robust trajectory underscores both the scientific progress and the increasing strategic complexity within the sector.

Scope & Segmentation

  • Therapy Types: Distinctions between cell therapies and gene therapies drive development and manufacturing requirements; cell therapies encompass stem cell and T cell approaches with unique technical and regulatory considerations.
  • Delivery Routes: Intramuscular and intravenous methods each necessitate specific infrastructure, patient monitoring, and clinical workflows, influencing selection and scaling of therapeutic approaches.
  • Clinical Indications: Diverse applications include cardiovascular, metabolic, neurological, oncology, and ophthalmology disorders, each with distinct development strategies and outcome measures.
  • Application Focus: Categories span clinical applications intended for disease treatment or prevention, and research and development efforts driven by discovery, translational validation, and early-stage testing.
  • End-User Environments: Academic institutes, hospitals, and clinics are pivotal in innovation, scale-up, and integration into care pathways, shaping adoption and commercialization opportunities.
  • Regions: In-depth comparative analysis covers the Americas, Europe Middle East & Africa, and Asia-Pacific, illuminating the impact of regional regulatory, funding, and infrastructure differences.
  • Technologies: Advances in cell editing, vector engineering, automated and modular manufacturing, and data-driven patient identification form the technological backbone of sector transformation.

Key Takeaways

  • Scientific advances are driving the transition from pioneering clinical research to scalable, industrialized therapy delivery, requiring adaptation by all stakeholders.
  • Organizations face rising complexity in supply chain management, regulatory strategy alignment, and operational capability building to support sustainable program growth.
  • Emerging commercial models, such as outcomes-based contracting and risk-sharing, are changing how therapies reach the market and how access is negotiated with payers and providers.
  • Strategic collaborations between pharmaceutical firms, biotech startups, contract development organizations, and academic centers are accelerating knowledge transfer and capability development.
  • Segmented approaches to development and go-to-market strategies enable tailored investments, addressing the distinct challenges and opportunities presented by different therapy types and clinical indications.
  • Investments in automated manufacturing and integrated data analytics support process consistency, regulatory compliance, and faster time to clinic for advanced therapies.

Tariff Impact

Recent United States tariff measures have increased complexity for global cell and gene therapy supply chains. Organizations are recalibrating procurement and manufacturing strategies to mitigate exposure to higher costs and disruptions. This has led to an increased emphasis on supplier diversification, qualification of alternative materials, and evaluation of nearshoring or onshoring options. Collaborative efforts between procurement, regulatory, and quality teams are essential to ensure ongoing compliance and minimize risk. Supply chain resilience has become a decisive strategic consideration for market participants.

Methodology & Data Sources

This report synthesizes insights from structured interviews with clinical researchers, manufacturing specialists, regulatory experts, and commercial leaders. Peer-reviewed literature, regulatory guidance, technology assessments, and corporate disclosures supplement the analysis, ensuring both practical relevance and technical accuracy. The approach emphasizes triangulation to validate findings and provide a balanced perspective on real-world implications.

Why This Report Matters

  • Equips executives with actionable strategies to strengthen supply resilience, align manufacturing and regulatory investments, and accelerate market access in a dynamic sector.
  • Maps relevant segmentations and regional differences to enable targeted development, partnership, and commercialization strategies.
  • Facilitates risk-aware decision-making and helps organizations prioritize investments according to strategic opportunity and operational feasibility.

Conclusion

The cell and gene therapy ecosystem is advancing rapidly, presenting both unprecedented opportunities and operational challenges. Executives who align scientific ambition with robust operational execution and strategic partnerships will lead the next phase of transformation and patient impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cell & Gene Therapy Market, by Therapy Type
8.1. Cell Therapy
8.1.1. Stem Cell Therapies
8.1.1.1. Hematopoietic Stem Cell Therapies
8.1.1.2. Mesenchymal Stem Cell Therapies
8.1.2. T Cell Therapy
8.1.2.1. CAR T Cell Therapy
8.1.2.2. T Cell Receptor (TCR)-based
8.2. Gene Therapy
8.2.1. Ex Vivo Gene Therapy
8.2.2. In Vivo Gene Therapy
9. Cell & Gene Therapy Market, by Delivery Method
9.1. Intramuscular
9.2. Intravenous
10. Cell & Gene Therapy Market, by Therapeutic Areas
10.1. Cardiovascular
10.1.1. Congestive Heart Failure
10.1.2. Ischemic Heart Disease
10.2. Metabolic Disorders
10.2.1. Diabetes
10.2.2. Obesity
10.3. Neurological Disorders
10.3.1. Alzheimer's Disease
10.3.2. Huntington's Disease
10.3.3. Multiple Sclerosis
10.3.4. Parkinson's Disease
10.3.5. Spinal Cord Injuries
10.4. Oncology
10.4.1. Hematological Malignancies
10.4.2. Lymphomas
10.4.3. Solid Tumors
10.5. Ophthalmology
11. Cell & Gene Therapy Market, by Application
11.1. Clinical Applications
11.1.1. Disease Prevention
11.1.2. Disease Treatment
11.2. Research & Development
12. Cell & Gene Therapy Market, by End User
12.1. Academic & Research Institutes
12.1.1. Private Research Labs
12.1.2. Universities
12.2. Hospitals & Clinics
13. Cell & Gene Therapy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cell & Gene Therapy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cell & Gene Therapy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cell & Gene Therapy Market
17. China Cell & Gene Therapy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Abeona Therapeutics Inc.
18.7. Adaptimmune Therapeutics PLC
18.8. AGC Inc.
18.9. Alnylam Pharmaceuticals, Inc.
18.10. American Gene Technologies Inc.
18.11. Amgen Inc.
18.12. AnGes, Inc
18.13. Astellas Pharma Inc.
18.14. Becton, Dickinson and Company
18.15. Biogen Inc.
18.16. Bluebird Bio, Inc.
18.17. BridgeBio Pharma, Inc.
18.18. Bristol-Myers Squibb Company
18.19. C.H. Boehringer Sohn AG & Co. KG
18.20. Cellectis SA
18.21. CRISPR Therapeutics AG
18.22. F. Hoffmann-La Roche AG
18.23. Gilead Sciences, Inc.
18.24. Intellia Therapeutics, Inc.
18.25. Ionis Pharmaceuticals, Inc.
18.26. Johnson & Johnson Services Inc.
18.27. Kyowa Kirin Co., Ltd.
18.28. Merck KGaA
18.29. Moderna, Inc.
18.30. Mustang Bio, Inc.
18.31. Novartis AG
18.32. Novo Nordisk A/S
18.33. Pfizer, Inc.
18.34. REGENXBIO Inc.
18.35. Sangamo Therapeutics, Inc.
18.36. Sarepta Therapeutics, Inc.
18.37. Shoreline Biosciences
18.38. Sibiono GeneTech Co. Ltd.
18.39. Syncona Limited
18.40. Thermo Fisher Scientific Inc.
18.41. Vertex Pharmaceuticals Incorporated
List of Figures
FIGURE 1. GLOBAL CELL & GENE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CELL & GENE THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CELL & GENE THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CELL & GENE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CELL & GENE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CELL & GENE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CAR T CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CAR T CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL RECEPTOR (TCR)-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL RECEPTOR (TCR)-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY T CELL RECEPTOR (TCR)-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY EX VIVO GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY EX VIVO GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY EX VIVO GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY IN VIVO GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY IN VIVO GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY IN VIVO GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OBESITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OBESITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HUNTINGTON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HUNTINGTON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SPINAL CORD INJURIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SPINAL CORD INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY LYMPHOMAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY LYMPHOMAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY LYMPHOMAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY DISEASE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PRIVATE RESEARCH LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY PRIVATE RESEARCH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. EUROPE CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 197. EUROPE CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 198. EUROPE CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 199. EUROPE CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 200. EUROPE CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 202. EUROPE CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 204. EUROPE CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. EUROPE CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. EUROPE CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 227. AFRICA CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 228. AFRICA CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 229. AFRICA CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 231. AFRICA CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 232. AFRICA CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 233. AFRICA CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 234. AFRICA CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 235. AFRICA CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 236. AFRICA CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. AFRICA CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 239. AFRICA CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. AFRICA CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. ASEAN CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. ASEAN CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 260. ASEAN CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 261. ASEAN CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 262. ASEAN CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 263. ASEAN CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 264. ASEAN CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 265. ASEAN CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 267. ASEAN CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 268. ASEAN CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 269. ASEAN CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 270. ASEAN CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. ASEAN CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 272. ASEAN CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. ASEAN CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 274. GCC CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. GCC CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 276. GCC CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 277. GCC CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 278. GCC CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 279. GCC CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 280. GCC CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 281. GCC CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 282. GCC CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 283. GCC CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 284. GCC CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 285. GCC CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 286. GCC CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. GCC CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 288. GCC CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. GCC CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 306. BRICS CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. BRICS CELL & GENE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 308. BRICS CELL & GENE THERAPY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 309. BRICS CELL & GENE THERAPY MARKET SIZE, BY STEM CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 310. BRICS CELL & GENE THERAPY MARKET SIZE, BY T CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 311. BRICS CELL & GENE THERAPY MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 312. BRICS CELL & GENE THERAPY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 313. BRICS CELL & GENE THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 314. BRICS CELL & GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 315. BRICS CELL & GENE THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 316. BRICS CELL & GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 317. BRICS CELL & GENE THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 318. BRICS CELL & GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 319. BRICS CELL & GENE THERAPY MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 320. BRICS CELL & GENE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. BRICS CELL & GENE THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MIL

Companies Mentioned

The key companies profiled in this Cell & Gene Therapy market report include:
  • AbbVie Inc.
  • Abeona Therapeutics Inc.
  • Adaptimmune Therapeutics PLC
  • AGC Inc.
  • Alnylam Pharmaceuticals, Inc.
  • American Gene Technologies Inc.
  • Amgen Inc.
  • AnGes, Inc
  • Astellas Pharma Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bluebird Bio, Inc.
  • BridgeBio Pharma, Inc.
  • Bristol-Myers Squibb Company
  • C.H. Boehringer Sohn AG & Co. KG
  • Cellectis SA
  • CRISPR Therapeutics AG
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Intellia Therapeutics, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Johnson & Johnson Services Inc.
  • Kyowa Kirin Co., Ltd.
  • Merck KGaA
  • Moderna, Inc.
  • Mustang Bio, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • REGENXBIO Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Shoreline Biosciences
  • Sibiono GeneTech Co. Ltd.
  • Syncona Limited
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 22.98 Billion
Forecasted Market Value ( USD ) by 2032 $ 71.38 Billion
Compound Annual Growth Rate20.3%
Regions CoveredGlobal
No. of Companies Mentioned38

Related Topics

Related Reports

Gene Therapy Market - Global Forecast 2026-2032 - Product Image

Gene Therapy Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Cell & Gene Therapy Clinical Trials Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Gene Therapy Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Regions, Leading Players and Sales Forecast - Product Image

Gene Therapy Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Regions, Leading Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From
Gene Therapy for Inherited Genetic Disorders Market Report 2025 - Product Image

Gene Therapy for Inherited Genetic Disorders Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.